NO SYNTHASE EXPRESSION IN GLOMERULAR ENDOTHELIAL CELLS
肾小球内皮细胞中没有合酶表达
基本信息
- 批准号:3081146
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 1997-07-31
- 项目状态:已结题
- 来源:
- 关键词:amine oxidoreductase antisense nucleic acid boranes calcium calmodulin cell line citrulline cyclic GMP cytokine enzyme activity enzyme induction /repression gene expression guanylate cyclase human tissue nitric oxide northern blottings peptidyl dipeptidase A prostaglandins renal glomerulus sulfur compounds superoxides temperature sensitive mutant transfection western blottings
项目摘要
The goals of the proposal are to define the biological role of nitric
oxide (N0) in the regulation of glomerular endothelial cell function. The
hypothesis is that expression of nitric oxide synthase (N0S) and
subsequent release of N0 by human glomerular endothelial (HGE) cells play
a key role in their function in both health and disease.
The initial aims will focus on investigating the physiological factors
which regulate N0 enzyme activation and molecular expression of N0S in
primary cultures of HGE cells. Due to the finite proliferation of HGE
cells and limited expression of N0 in vitro, the major thrust of the
project will be directed at the development and testing of appropriate
vector systems which will allow for conditional immortalization of HGE
cells. Conditional immortalization will be achieved using a recombinant
retroviral construct encoding the temperature - sensitive mutant of SV4
large T antigen. This thermolabile transforming protein is active at
permissive temperature (33 degrees C) but degrades at temperatures greater
than 37 degrees C. Developing HGE cell lines is a crucial first step in
deciphering the functional role of N0 in these cells. To characterize
which particular isoform exist in both primary HGE cells and in HGE cell
lines studies will be designed to activate the calcium dependent
(constitutive) and the cytokine inducible isoforms of N0S. N0 activity
will be measured utilizing the following biochemical assays l) citrulline
forming assay and 2) activation of guanylate cyclase in reporter rat
fibroblast cell line, sensitive index of the formation of NO. Molecular
expression of N0S will be characterized by Western and Northern blot
analysis. Both biochemical and molecular studies will be directed at
defining the regulator mechanisms of N0 activation. Subsequently, we will
develop HGE cell line which over or under - express NOS and examine the
physiological effects on HGE cell function.
该提案的目标是确定氮的生物作用
氧化物(N0)在肾小球内皮细胞功能的调节。 的
假设是一氧化氮合酶(NOS)表达,
人肾小球内皮细胞(HGE)随后释放N0
在健康和疾病中发挥关键作用。
最初的目标将集中在调查生理因素
其调节N0酶的活化和N0S的分子表达,
HGE细胞的原代培养物。 由于HGE的有限增殖,
细胞和N0在体外的有限表达,
该项目将针对开发和测试适当的
允许HGE有条件永生化的载体系统
细胞 条件性永生化将使用重组的
编码SV4温度敏感突变体的逆转录病毒构建体
大T抗原。 这种不耐热的转化蛋白在
允许温度(33摄氏度),但在更高的温度下会降解
超过37摄氏度。开发HGE细胞系是关键的第一步,
破译N0在这些细胞中的功能作用。 表征
所述特定同种型存在于原代HGE细胞和HGE细胞中
线研究将被设计为激活钙依赖性
(组成型)和细胞因子诱导型NOS同种型。 NO活性
将使用以下生化测定进行测量1)瓜氨酸
报告大鼠鸟苷酸环化酶的活化
成纤维细胞系,NO形成的敏感指标。分子
将通过Western和北方印迹来表征NOS的表达
分析. 生物化学和分子研究都将针对
定义N0激活的调节机制。 后续我们将
建立过表达或低表达NOS的HGE细胞系,
对HGE细胞功能的生理影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOLLIE F. GREEN其他文献
DOLLIE F. GREEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOLLIE F. GREEN', 18)}}的其他基金
NO SYNTHASE EXPRESSION IN GLOMERULAR ENDOTHELIAL CELLS
肾小球内皮细胞中没有合酶表达
- 批准号:
2134080 - 财政年份:1993
- 资助金额:
$ 7.55万 - 项目类别:
NO SYNTHASE EXPRESSION IN GLOMERULAR ENDOTHELIAL CELLS
肾小球内皮细胞中没有合酶表达
- 批准号:
2134081 - 财政年份:1993
- 资助金额:
$ 7.55万 - 项目类别:
NO SYNTHASE EXPRESSION IN GLOMERULAR ENDOTHELIAL CELLS
肾小球内皮细胞中没有合酶表达
- 批准号:
2134082 - 财政年份:1993
- 资助金额:
$ 7.55万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)